about
Longitudinal Small-Animal PET Imaging of the zQ175 Mouse Model of Huntington Disease Shows In Vivo Changes of Molecular Targets in the Striatum and Cerebral Cortex.Comparative binding properties of the tau PET tracers THK5117, THK5351, PBB3, and T807 in postmortem Alzheimer brains.[11C]AZ10419096 - a full antagonist PET radioligand for imaging brain 5-HT1B receptors.Identification of a Novel Positron Emission Tomography (PET) Ligand for Imaging β-Site Amyloid Precursor Protein Cleaving Enzyme 1 (BACE-1) in Brain.Synthesis and evaluation of two new candidate high-affinity full agonist PET radioligands for imaging 5-HT1B receptors.PET imaging of beta-secretase 1 in the human brain: radiation dosimetry, quantification, and test-retest examination of [18F]PF-06684511Synthesis, Biodistribution, and Radiation Dosimetry of a Novel mGluR5 Radioligand: 18F-AZD9272Quantitative Analysis of 18F-PF-06684511, a Novel PET Radioligand for Selective β-Secretase 1 Imaging, in Nonhuman Primate BrainThe pro-psychotic metabotropic glutamate receptor compounds fenobam and AZD9272 share binding sites with monoamine oxidase-B inhibitors in humansCharacterization of [11C]PXT012253 as a PET Radioligand for mGlu4 Allosteric Modulators in Nonhuman PrimatesDevelopment of a 18F-labeled PET radioligand for imaging 5-HT1B receptors: [18F]AZ10419096Potential for imaging the high-affinity state of the 5-HT1B receptor: a comparison of three PET radioligands with differing intrinsic activitySynthesis and preclinical evaluation of [18F]FSL25.1188, a reversible PET radioligand for monoamine oxidase-BPET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease ProgressionIdentification and Development of an Irreversible Monoacylglycerol Lipase (MAGL) Positron Emission Tomography (PET) Radioligand with High SpecificitySynthesis and biological evaluation of [18F]fluorovinpocetine, a potential PET radioligand for TSPO imaging
P50
Q39179544-20D84C61-3B1C-42BD-B3C7-8C705BCEA244Q47140361-C20C82A3-3CBA-48EA-9261-97CE6811373CQ47613056-0061B553-D0D5-4C95-893B-D3C18B620893Q47847829-54F2B97B-3CC7-48F5-9B6E-8A1093455D7DQ64885311-4718CEC5-4F7D-43DB-9768-F49C06465E69Q90096198-69DC2451-091B-4356-A03D-853F6FC60729Q90298804-FC02F042-3E65-44FC-AC47-CCC023733354Q90366038-07CEE621-731E-4D58-B261-DCFFD7191FB3Q90565004-B4E8A93D-1FCD-4BDF-8727-56F6A556B0D4Q90678423-CFB97DE5-97D6-4929-B54B-01D97A4E85DDQ91072087-EE18B77D-BA59-4693-98FE-BD7F4B43A8EDQ91389848-2EDC9FB6-B61C-4849-8EFE-FA70EA5D82EEQ91801178-96AA093B-DD38-4873-9F0C-432F1D3AF805Q92844930-B62C132C-6933-4C94-B1C2-61E1541C4CECQ93095494-FAFA638A-DE77-4056-9245-551D50799EB9Q93138054-469D74BD-5836-4E13-B284-3B0019D60E5F
P50
description
researcher
@en
wetenschapper
@nl
name
Sangram Nag
@en
Sangram Nag
@nl
type
label
Sangram Nag
@en
Sangram Nag
@nl
prefLabel
Sangram Nag
@en
Sangram Nag
@nl
P31
P496
0000-0003-3590-4256